Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-15-006379
Filing Date
2015-08-10
Accepted
2015-08-10 16:09:10
Documents
12
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ovas-20150630x10q.htm 10-Q 673992
2 EXHIBIT 10.1 ovas-20150630xex101.htm EX-10.1 370883
3 EXHIBIT 31.1 ovas-20150630xex311.htm EX-31.1 13084
4 EXHIBIT 31.2 ovas-20150630xex312.htm EX-31.2 12358
5 EXHIBIT 32.1 ovas-20150630xex321.htm EX-32.1 8191
6 EXHIBIT 32.2 ovas-20150630xex322.htm EX-32.2 7434
  Complete submission text file 0001628280-15-006379.txt   4056054

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ovas-20150630.xml EX-101.INS 788467
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ovas-20150630.xsd EX-101.SCH 26440
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ovas-20150630_cal.xml EX-101.CAL 45866
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ovas-20150630_def.xml EX-101.DEF 111024
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ovas-20150630_lab.xml EX-101.LAB 389545
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ovas-20150630_pre.xml EX-101.PRE 206977
Mailing Address 215 FIRST STREET SUITE 240 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 240 CAMBRIDGE MA 02142 617-500-2802
OvaScience, Inc. (Filer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35890 | Film No.: 151040829
SIC: 2834 Pharmaceutical Preparations